CVE-2022-45927

Public Exploit

Description

An issue was discovered in OpenText Content Suite Platform 22.1 (16.2.19.1803). The Java application server can be used to bypass the authentication of the QDS endpoints of the Content Server. These endpoints can be used to create objects and execute arbitrary code.

Category

8.8
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.07%
Third-Party Advisory packetstormsecurity.com Third-Party Advisory seclists.org Third-Party Advisory sec-consult.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://sec-consult.com/vulnerability-lab/advisory/pre-authenticated-remote-code-execution-via-java-frontend-qds-endpoint-opentext-extended-ecm/ third party advisory exploit
http://seclists.org/fulldisclosure/2023/Jan/13 mailing list third party advisory exploit
http://packetstormsecurity.com/files/170614/OpenText-Extended-ECM-22.3-Java-Frontend-Remote-Code-Execution.html third party advisory vdb entry exploit

Frequently Asked Questions

What is the severity of CVE-2022-45927?
CVE-2022-45927 has been scored as a high severity vulnerability.
How to fix CVE-2022-45927?
To fix CVE-2022-45927, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-45927 being actively exploited in the wild?
It is possible that CVE-2022-45927 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.